The biological hybrid nanoparticles were synthesized by fusion of CD47-expressing tumor exosomes and tumor-targeting peptide cRGD (cyclic arginine-glycine-aspartic acid) modified liposomes (miR497/ TP-henPs), which were responsible for the delivery of miR497 and TP. Here, CD47 is linked to neoplasm.